Pelago Bioscience AB and AstraZeneca have entered into a 2-year strategic research collaboration and license agreement.
The companies will collaborate on specified joint projects and AstraZeneca will also be granted a license to use and apply the Cellular Thermal Shift Assay (CETSA®) for determ